Gilead Sciences

VP, Program Strategy Leader

Posted on: 30 Jan 2021

Foster City, CA

Job Description

Gilead Sciences is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over the coming weeks and months, we will be implementing a phased approach to bringing employees back to site to ensure the health and safety of our teams.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Job Description



The Program Strategy Leader (PSL) is accountable for leading a cross-functional team to advance one or more programs through clinical and technical development; regulatory submission; manufacturing; and commercialization. The PSL serves to integrate cross-functional input, synthesize team recommendations, and direct the program through corporate governance, while maintaining adherence to timelines and budget. Lastly, PSL is expected to maintain consistent, multi-level communication with Development Team Members, Commercial Team Members, Manufacturing Team Members, and others including Senior Management, and the Executive Team.

Specific Responsibilities:

* Partner with cross-functional leaders to develop comprehensive product development and lifecycle management plans (Non-Clinical, Clinical, CMC, Regulatory, Commercial) that optimize: value, time, resources, risk, and alignment with business objectives

* In collaboration with cross-functional team and working closely with Project Management:

* Develop and implement product development and lifecycle management plans

* Develop vision and strategy for the asset and a plan to achieve potential

* Identify and manage critical path activities and resources

* Identify and manage interdependencies and hand-offs

* Identify and proactively mitigate roadblocks

* Identify and document risks, likelihoods, severities, and key mitigations

* Lead contingency planning

* Capture and communicate progress; escalate potential delays with proposed solutions

* Direct programs through corporate governance to ensure that:

* Projects have adequate resources and technical expertise to meet strategic objectives

* Issues are raised, discussed, and resolved in a timely manner

* Project teams receive management decisions in a timely manner

* Programs adhere to agreed-upon scope, timelines, resources, and budget

* Accountable for clear and timely communication about the program throughout the enterprise such as via: agendas, minutes, townhalls and other communication methods

* Responsible for facilitating Program Strategy Team meetings and working with Development Team Leader, Commercial Team Leader, and other Subteam Leaders to ensure subteams and PST are working in alignment on strategic and operational topics.

* Present project updates, strategic issues, options, and recommendations to the Portfolio Committee

* The PSL is responsible to contribute to the development of cross-functional team members; to freely share expertise and help identify opportunities for team members to grow as leaders

* The PSL must have the ability to drive the development of drug candidates into therapeutics that can be filed, approved by regulatory agencies, manufactured, and successfully commercialized.

Additional Responsibilities:

* May work with Development and Commercial Therapeutic Area Leaders to define the disease area strategy for discovery and early development in that area and execute on a business plan with clear deliverables and resource needs. This includes defining priorities and an approach to leveraging external opportunities in close collaboration with External Innovation, Business Development and academic experts.

* Drive close alignment among research, development, and commercial groups to ensure the focus and prioritization of assets that are considered to provide the greatest clinical/medical as well as commercial value in the long-term.

* Communication: Advocates on behalf of Gilead and effectively communicates scientific/medical/clinical concepts in both written and oral communication to both internal and external stakeholders.

Capabilities and Requirements:

* Strong leadership skills from leading cross-functional teams in a matrix organization, with highly collaborative instincts and a track record of resolving conflicts within the team

* Ability to communicate clearly and effectively with clinical scientists, biologists, manufacturing experts, as well as with regulatory and commercial colleagues at all levels of the organization

* High degree of organizational awareness and understanding of change management and leading innovation

* You have significant depth and breadth of experience including that enable you to immediately bring considerable strategic value to a project

* You have robust drug development experience and understand what it takes to shepherd a molecule through its lifecycle to realize maximum value for its targeted population(s) and Gilead

Education and Qualifications:

* Bachelor's degree in a scientific discipline; advanced or professional degree highly desirable (e.g., PhD, MD, or MBA)

* 10+ years of biopharmaceutical industry experience with at least 8 years of relevant work experiences in the biotech/pharmaceutical industry.

* Must demonstrate knowledge of the overall drug development process relevant to biotech/ pharmaceutical companies; early drug development experience is highly desirable.

Gilead Core Values

* Integrity (Doing Whats Right)

* Inclusion (Encouraging Diversity)

* Teamwork (Working Together)

* Excellence (Being Your Best)

* Accountability (Taking Personal Responsibility)

As an equal opportunity employer, Gilead Sciences, Inc. is committed to a diverse workforce. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance.


For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance.

For more information about equal employment opportunity protections, please view the EEO is the Law poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

PAY TRANSPARENCY NONDISCRIMINATION PROVISION

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.


For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Gilead Sciences

Foster City, CA

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.

It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of HIV/AIDS and liver diseases, hematology/oncology, inflammation/respiratory diseases, and others.

The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Scholar Rock Holding Corporation; Tango Therapeutics; National Cancer Institute; Pfizer, Inc.; Sangamo Therapeutics, Inc.; Gadeta B.V.; HiFiBiO Therapeutics; Agenus Inc.; HOOKIPA Pharma Inc.; Goldfinch Bio, Inc.; and insitro Inc. The company was founded in 1987 and is headquartered in Foster City, California.